Nykode Therapeutics AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,068	788	995	6,988	8,287	23,372
Market Cap Growth	22.84%	-20.81%	-85.77%	-15.67%	-64.54%	9.44%
Enterprise Value	591	178	-270	5,353	6,040	21,724
Last Close Price	3.27	2.41	1.99	13.98	18.37	52.72
Forward PE	-	-	-	-	4.32	4.32
PS Ratio	197.19	172.48	9.56	51.73	93.16	74.18
PB Ratio	1.25	0.85	0.64	4.02	5.36	13.67
P/TBV Ratio	1.25	0.85	0.64	4.03	5.36	13.67
P/FCF Ratio	-	-	-	-	-	9341.31
P/OCF Ratio	-	-	-	-	-	2296.91
EV/Sales Ratio	109.15	38.99	-	39.62	67.90	68.94
EV/FCF Ratio	-2.11	-	-	-	-	8682.61
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.04
Debt / FCF Ratio	-	-	-	-	-	25.25
Net Debt / Equity Ratio	-0.56	-0.63	-0.82	-0.92	-1.28	-1.14
Net Debt / EBITDA Ratio	1.82	2.07	2.35	2.73	3.81	20.70
Net Debt / FCF Ratio	1.71	1.96	2.18	1.59	8.60	-778.98
Asset Turnover	0.01	0.00	0.05	0.06	0.04	0.14
Quick Ratio	12.66	9.88	12.78	7.94	5.41	8.12
Current Ratio	12.66	9.99	12.87	8.04	5.44	8.16
Return on Equity (ROE)	-13.46%	-10.75%	-25.25%	-21.42%	-24.35%	-5.05%
Return on Assets (ROA)	-14.34%	-14.10%	-16.70%	-16.90%	-13.64%	-2.72%
Return on Invested Capital (ROIC)	-76.23%	-98.49%	-250.18%	-	-	-
Return on Capital Employed (ROCE)	-30.80%	-30.50%	-33.50%	-31.00%	-29.10%	-4.60%
Earnings Yield	-13.60%	-15.67%	-44.34%	-5.10%	-5.08%	-0.36%
FCF Yield	-26.18%	-37.75%	-58.58%	-14.30%	-2.78%	0.01%
Dividend Yield	29.76%	-	50.26%	-	-	-
Buyback Yield / Dilution	-	-	-8.66%	-3.58%	-1.32%	3.31%
Total Shareholder Return	29.76%	-	41.60%	-3.58%	-1.32%	3.31%